Indoco Remedies Ltd (INDOCO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Indoco Remedies Ltd (INDOCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2819
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Indoco Remedies Ltd (Indoco Remedies) is a research-oriented pharmaceutical company that manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). It has products portfolio in various therapeutic segments such as cardiovascular, central nervous system, respiratory, anti infective, ophthalmic, cardiovascular, antiinflammatory, anti- diabetics, dental care, pain management, gastrointestinal, anti obesity, musculo-skeletal, nutrition and others. Indoco operates its manufacturing facilities for finished dosages and APIs supported by research and development centre spread across India. The company has operations and market presence in Europe, the US, Latin America, Asia, Africa, and other CIS countries. Indoco Remedies is headquartered in Mumbai, Maharashtra, India.

Indoco Remedies Ltd (INDOCO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indoco Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 11
Private Equity 12
Baring Private Equity Partners Acquires 3.4% Stake In Indoco Remedies For US$1.7 Million 12
Partnerships 13
DSM Pharma Enters Into Co-Marketing Agreement With Indoco Remedies For APIs 13
Acquisition 14
Barclays Merchant Bank Acquires Stake in Indoco Remedies from Baring Private Equity Partners India 14
Indoco Remedies Ltd – Key Competitors 15
Indoco Remedies Ltd – Key Employees 16
Indoco Remedies Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 07, 2017: Indoco’s Net Profit at Rs 19.76 Crores 18
Aug 09, 2017: Indoco Remedies reports Q1 fiscal 2018 results 19
Legal and Regulatory 20
May 18, 2018: Indoco Remedies Completes US FDA Inspection at API Manufacturing Facility In Mumbai 20
Mar 27, 2018: Indoco Remedies: UK-MHRA inspection report 21
Feb 15, 2018: Indoco Remedies: EU GMP Certification of Goa Plant III 22
Feb 12, 2018: Indoco Remedies: USFDA Inspection of Goa Plant 1 23
Mar 31, 2017: indoco remedies Provides Update On US FDA Inspection At Drug Manufacturing Facility In Goa 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indoco Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indoco Remedies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 11
Baring Private Equity Partners Acquires 3.4% Stake In Indoco Remedies For US$1.7 Million 12
DSM Pharma Enters Into Co-Marketing Agreement With Indoco Remedies For APIs 13
Barclays Merchant Bank Acquires Stake in Indoco Remedies from Baring Private Equity Partners India 14
Indoco Remedies Ltd, Key Competitors 15
Indoco Remedies Ltd, Key Employees 16
Indoco Remedies Ltd, Subsidiaries 17

List of Figures
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Indoco Remedies Ltd (INDOCO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korea Electric Power Corporation:企業のM&A・事業提携・投資動向
    Korea Electric Power Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Korea Electric Power Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Luminex Corp (LMNX):企業の財務・戦略的SWOT分析
    Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Societe Tunisienne de l’Electricite et du Gaz:電力:M&Aディール及び事業提携情報
    Summary Societe Tunisienne de l'Electricite et du Gaz (STEG) is a non-administrative Tunisian public company that produces liquefied petroleum gas (LPG) and electricity, transports, and distributes electricity and natural gas. As a public company, its mandate includes developing the natural gas netw …
  • Tel-Instrument Electronics Corp.:企業の戦略・SWOT・財務分析
    Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report Summary Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • Techpool Bio-Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Techpool Bio-Pharma Co Ltd (Techpool Bio-Pharma) is a biopharmaceutical company. The company manufactures urinary protein biopharmaceuticals in critical care conditions. The company’s products include ulinastatin for injection, urinary kallidinogenase for injection, urokinase for injection a …
  • IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析
    Summary IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes i …
  • Peyto Exploration & Development Corp (PEY):企業の財務・戦略的SWOT分析
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consu …
  • Tactical Missiles Corporation:企業の戦略・SWOT・財務情報
    Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report Summary Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • GridEdge Networks Inc:企業の戦略的SWOT分析
    GridEdge Networks Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Attijari Bank SA:企業の戦略・SWOT・財務分析
    Attijari Bank SA - Strategy, SWOT and Corporate Finance Report Summary Attijari Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Keck Seng Investments (Hong Kong) Ltd:企業の戦略・SWOT・財務情報
    Keck Seng Investments (Hong Kong) Ltd - Strategy, SWOT and Corporate Finance Report Summary Keck Seng Investments (Hong Kong) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Raia Drogasil SA:企業の戦略・SWOT・財務分析
    Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report Summary Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tower International Inc:企業の戦略的SWOT分析
    Tower International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Allied International Corporation:企業の戦略・SWOT・財務情報
    Allied International Corporation - Strategy, SWOT and Corporate Finance Report Summary Allied International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Carraro Spa:企業の戦略・SWOT・財務情報
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Wacoal Holdings Corp (3591):企業の財務・戦略的SWOT分析
    Wacoal Holdings Corp (3591) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CompuGroup Medical Deutschland AG (COP)-医療機器分野:企業M&A・提携分析
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company's products comprise communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety, patient marketing, and ot …
  • Royal FrieslandCampina N.V.:企業の戦略・SWOT・財務情報
    Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆